Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of Clinical Microbiology
|
March 1, 1994
Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans
J S Youngner, J J Treanor, R F Betts, et al.
Virology
|
November 1, 1983
Superinfection exclusion by vesicular stomatitis virus
P Whitaker-Dowling, J S Youngner, C C Widnell, et al.
Virology
|
October 1, 1988
Characterization of a unique protein produced by influenza A virus recovered from a long-term persistent infection
W T Lucas, P Whitaker-Dowling, C R Kaifer, et al.
Cancer Gene Therapy
|
July 26, 2008
Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
Y Gao, P Whitaker-Dowling, J A Griffin, et al.
American Journal of Veterinary Research
|
August 11, 2001
Derivation and characterization of a live attenuated equine influenza vaccine virus
J S Youngner, P Whitaker-Dowling, T M Chambers, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
March 1, 1990
Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells
G Lancz, P Whitaker-Dowling, Y V Marsh, et al.
Journal of the American Veterinary Medical Association
|
April 11, 2001
Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression
D P Lunn, S Hussey, R Sebing, et al.
Equine Veterinary Journal
|
January 5, 2002
Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials
H G Townsend, S J Penner, T C Watts, et al.
Equine Veterinary Journal
|
January 5, 2002
A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge
T M Chambers, R E Holland, L R Tudor, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of Clinical Microbiology
|
March 1, 1994
Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans
J S Youngner, J J Treanor, R F Betts, et al.
Virology
|
November 1, 1983
Superinfection exclusion by vesicular stomatitis virus
P Whitaker-Dowling, J S Youngner, C C Widnell, et al.
Virology
|
October 1, 1988
Characterization of a unique protein produced by influenza A virus recovered from a long-term persistent infection
W T Lucas, P Whitaker-Dowling, C R Kaifer, et al.
Cancer Gene Therapy
|
July 26, 2008
Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
Y Gao, P Whitaker-Dowling, J A Griffin, et al.
American Journal of Veterinary Research
|
August 11, 2001
Derivation and characterization of a live attenuated equine influenza vaccine virus
J S Youngner, P Whitaker-Dowling, T M Chambers, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
March 1, 1990
Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells
G Lancz, P Whitaker-Dowling, Y V Marsh, et al.
Journal of the American Veterinary Medical Association
|
April 11, 2001
Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression
D P Lunn, S Hussey, R Sebing, et al.
Equine Veterinary Journal
|
January 5, 2002
Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials
H G Townsend, S J Penner, T C Watts, et al.
Equine Veterinary Journal
|
January 5, 2002
A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge
T M Chambers, R E Holland, L R Tudor, et al.
Page
of 3